Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Blood Safety”

5,532 trials

Showing 20 of 5,532 results

Testing effectiveness (Phase 2)Study completedNCT00415051
What this trial is testing

Safety/Immunogenicity/Genetic Drift of MP-12 Rift Valley Fever Vaccine

Who this might be right for
Rift Valley Fever
U.S. Army Medical Research and Development Command 20
Testing effectiveness (Phase 2)Study completedNCT03640312
What this trial is testing

Efficacy and Safety of a Quadruple Ultra-low-dose Treatment for Hypertension

Who this might be right for
Hypertension
Washington University School of Medicine 62
Testing effectiveness (Phase 2)Study completedNCT00711230
What this trial is testing

Repeated DermaVir Immunizations in HIV-1 Infected Treatment-naïve Patients

Who this might be right for
HIV Infection
Genetic Immunity 36
Testing effectiveness (Phase 2)Study completedNCT00860600
What this trial is testing

Safety and Efficacy Study of PG2 to Treat Idiopathic Thrombocytopenic Purpura (ITP) Patients

Who this might be right for
Idiopathic Thrombocytopenic Purpura (ITP)
PhytoHealth Corporation 14
Testing effectiveness (Phase 2)Study completedNCT00537407
What this trial is testing

Debio 025 in Combination With PegIFN Alpha-2a and Ribavirin in Chronic HCV Patients Non-responders to Standard Treatment

Who this might be right for
Chronic Hepatitis C
Debiopharm International SA 50
Early research (Phase 1)UnknownNCT03015922
What this trial is testing

Viral Immunotherapy in Relapsed/Refractory Multiple Myeloma

Who this might be right for
Multiple Myeloma
University of Leeds 4
Post-approval studies (Phase 4)Active Not RecruitingNCT07154537
What this trial is testing

Pneumococcal Conjugated Vaccine 13 (PCV13) for Patients With Multiple Myeloma (MM)

Who this might be right for
Multiple Myeloma
National Taiwan University Hospital 101
Not applicableStudy completedNCT03740230
What this trial is testing

An Observational Study of Maviret (Glecaprevir/Pibrentasvir) for Korean Chronic Hepatitis C Genotypes 1 to 6 Patients According to the Standard for Re-examination of New Drugs

Who this might be right for
Hepatitis C
AbbVie 3,134
Large-scale testing (Phase 3)Study completedNCT02671500
What this trial is testing

Efficacy and Safety of Sofosbuvir/Velpatasvir Fixed Dose Combination for 12 Weeks in Participants With Chronic HCV

Who this might be right for
Hepatitis C Virus Infection
Gilead Sciences 375
Early research (Phase 1)Ended earlyNCT02797522
What this trial is testing

ARC-521 Injection in Normal Adult Volunteers and Patients With Chronic Hepatitis B (CHB)

Who this might be right for
Hepatitis B
Arrowhead Pharmaceuticals 47
Testing effectiveness (Phase 2)Study completedNCT01155037
What this trial is testing

Safety of and Immunogenicity to an H1N1 Influenza Vaccine in HIV-infected Adults

Who this might be right for
HIV Infection
Oswaldo Cruz Foundation 450
Testing effectiveness (Phase 2)Study completedNCT00994929
What this trial is testing

Efficacy and Safety of IL-11 in DDAVP Unresponsive

Who this might be right for
Hemophilia AVon Willebrand Disease
University of Pittsburgh 9
Testing effectiveness (Phase 2)Study completedNCT00002265
What this trial is testing

An Open-Label, Multicenter Study to Evaluate the Safety and Tolerability of Dideoxycytidine (ddC) in Patients With AIDS or Advanced ARC Who Previously Demonstrated Intolerance to Zidovudine (AZT) in Protocol N3300 or N3492

Who this might be right for
HIV Infections
Hoffmann-La Roche
Testing effectiveness (Phase 2)Study completedNCT04439539
What this trial is testing

JNJ-73763989, Pegylated Interferon Alpha-2a, Nucleos(t)Ide Analog (NA) With or Without JNJ-56136379 in Treatment-naive Participants With Hepatitis B e Antigen (HBeAg) Positive Chronic Hepatitis B Virus (HBV) Infection

Who this might be right for
Hepatitis B, Chronic
Janssen Research & Development, LLC 54
Large-scale testing (Phase 3)Study completedNCT00687219
What this trial is testing

Efficacy and Safety of Peginterferon Alfa-2b and Ribavirin Therapy in Subjects With Type C Compensated Liver Cirrhosis (Study P05116)

Who this might be right for
Hepatitis C, ChronicLiver Cirrhosis
Merck Sharp & Dohme LLC 102
Early research (Phase 1)Study completedNCT03430830
What this trial is testing

Evaluate the Pharmacokinetics and Safety of ASC16 Tablets in Healthy Volunteers in China

Who this might be right for
Chronic Hepatitis c
Ascletis Pharmaceuticals Co., Ltd. 12
Not applicableStudy completedNCT01524900
What this trial is testing

Observational Study of Nevirapine Extended Release in Human Immunodeficiency Virus (HIV) Patients in Daily Clinical Practice

Who this might be right for
HIV Infections
Boehringer Ingelheim 398
Early research (Phase 1)Study completedNCT00555100
What this trial is testing

Safety Study of Lenalidomide With and Without Dexamethasone in Japanese Subjects With Previously Treated Multiple Myeloma

Who this might be right for
Multiple Myeloma
Celgene 15
Testing effectiveness (Phase 2)WithdrawnNCT02462772
What this trial is testing

Safety and Acceptability of Cabotegravir in HIV Uninfected Women in KwaZulu-Natal, South Africa

Who this might be right for
Human Immunodeficiency Virus
Centre for the AIDS Programme of Research in South Africa
Testing effectiveness (Phase 2)Study completedNCT03294798
What this trial is testing

Study of Recombinant Human Serum Albumin/Interferon alpha2b Fusion Protein in Hepatitis B Patient

Who this might be right for
Hepatitis B Virus
Tianjin SinoBiotech Ltd. 11
Load More Results

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation